Company Filing History:
Years Active: 2020-2022
Title: The Innovations of Karl-Heinz Bannefeld
Introduction
Karl-Heinz Bannefeld is a notable inventor based in Münster, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of multiple myeloma. With a total of two patents to his name, Bannefeld's work has the potential to impact cancer treatment significantly.
Latest Patents
Bannefeld's latest patents focus on compositions comprising dexamethasone. These pharmaceutical compositions are designed for the treatment of multiple myeloma in combination with anti-cancer drugs. The formulations include high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof, showcasing his innovative approach to cancer therapy.
Career Highlights
Throughout his career, Bannefeld has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Dexcel Pharma Technologies Ltd. and Haupt Pharma Münster GmbH. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical compositions.
Collaborations
Bannefeld has collaborated with several professionals in his field, including Caterina Kreyenborg and Elisabeth Meimberg. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented compositions.
Conclusion
Karl-Heinz Bannefeld's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor. His patents reflect a commitment to improving therapeutic options for patients with multiple myeloma.